Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Imagerie cérébrale Oumesmar Zujovic

What are the symptoms of multiple sclerosis (MS)?

Last update: 22/07/2025 Reading time: 1min

Multiple sclerosis diagnosis requires this combination of neurological symptoms with the presence of inflammatory plaques in an MRI scan, to see which have both spatial dissemination (brain, spinal cord, optic nerve) and temporal dissemination (inflammatory plaques of different ages or that appear over time).

Symptoms

Symptoms of multiple sclerosis

The symptoms are extremely varied according to the area of the brain, spinal cord or optic nerves where the inflammatory attack occurs. They can therefore manifest as:

  • sensitivity disorders (pins and needles, tingling, feeling a cold or prickling sensation on the skin, a feeling of tightness or pain)
  • muscle paralysis or weakness leading to problems walking
  • balance problems
  • visual impairment. The disorder results in a loss of visual acuity that can be accompanied by pain around the eye socket, especially when the eye is moving.

In some cases, the starting symptoms may differ between two episodes. For example, one with sensitivity problems in a lower limb, but then a few weeks later problems with vision.

The symptoms of multiple sclerosis (MS) differ greatly from one patient to another. The spread of lesions over time and in different regions of the brain and spinal cord explains why there is so much variation in symptoms in the same patient, as well as between patients.

The most well-known symptoms of the disease are its motor symptoms. Problems with walking, or with moving a lower or upper limb, are all external signs visible to those around the patient. However, although the symptoms of multiple sclerosis can be very debilitating for a person in their everyday life, not all are noticeable and are therefore less well understood and accepted by the patients’ friends and relatives. These symptoms include fatigue and tiring easily, affecting 75 to 95% of patients with MS. This fatigue can be physical as well as mental and can have a considerable impact on patients’ daily lives. Another of the invisible symptoms is cognitive impairment, which presents as problems with attention, concentration, memory, and executive function disorders such as decision-making, planning, organization, etc. Finally, mood or emotional disorders may also be present.

Les symptômes de la sclérose en plaques

In the first few years of the disease, in more than 80% of cases, the disease progresses as inflammatory flare-ups (recurrent-remitting form). A flare-up typically begins within a few days or months and lasts around 2 to 8 weeks. After several years, some patients develop a secondary progressive form. The time to onset of this form can vary widely between individuals and could depend on individual recovery capacity. The other 20% of patients present with a progressive form from the outset. The progression and time to onset of irreversible disability vary according to each person’s ability to ‘repair’ their brain damage.

Our news on the subject

Monocyte – un globule blanc qui se différencie en macrophage. Crédit : Université d’Edinbourg.
Discovery of a Macrophage Anomaly in Multiple Sclerosis
Certain patients with multiple sclerosis (MS) can partially regenerate myelin—the protective sheath that surrounds nerve fibers—which is damaged during the evolution of the disease. In studying how immune cells influence this remyelination...
12.19.2024 Research, science & health
First demonstration of the neuroprotective effect of remyelination in multiple sclerosis patients
First demonstration of the neuroprotective effect of remyelination in multiple sclerosis patients
In an article recently published in the European Journal of Neurology, Vito Ricigliano (AP-HP), Benedetta Bodini (AP-HP/Sorbonne University) and their collaborators at the Paris Brain Institute, demonstrate the protective effect of myelin repair on...
02.24.2022 Research, science & health
Neurone de la rétine prolongé par un long axone entouré de sa gaine de myéline. Crédit : Annie Cavanagh, Wellcome collection.
Early cortical remyelination has a neuroprotective effect in multiple sclerosis
Multiple sclerosis is a heterogeneous disease whose manifestations vary considerably from patient to patient and whose course appears, on the surface, unpredictable. Hence, it is crucial to identify the factors that drive disability progression. In a...
04.02.2024 Research, science & health
sclérose en plaques
Multiple sclerosis: new study highlights five warning signs of the disease
What if the biological mechanisms that cause multiple sclerosis were triggered years before clinical diagnosis? This is what a team at Paris Brain Institute suggests in a new study published in Neurology. The researchers show that, on a population...
12.06.2023 Research, science & health
Têtard de Xénope transgénique chez lequel la substance blanche (myéline) apparaît par fluorescence, en vert. Crédit : David Akbar (plateforme ICM Quant) et Elodie Martin (Equipe Lubetzki/Stankoff).
Multiple sclerosis: a new tool to reduce clinical failure
No treatment currently exists that can stop the silent progression of multiple sclerosis, and many promising drugs have proved ineffective in clinical trials. To reduce this failure rate and better predict the potential of candidate molecules...
03.03.2023 Research, science & health
image
New data on inflammation in multiple sclerosis using PET-MRI
Several studies by Prof. Bruno Stankoff's team "Remyelination in multiple sclerosis: from biology to clinical translation", highlight new mechanisms of brain inflammation in multiple sclerosis, thanks to new imaging tools based on the combination of...
10.20.2021 Research, science & health
See all our news